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Evidence of a high incidence of subclinically
affected calves in a herd of cattle with fatal cases
of Bovine Neonatal Pancytopenia (BNP)
Charlotte R Bell1*, Morag G Kerr2, Philip R Scott3, W Ivan Morrison1 and Helen Brown1
Abstract
Background: Bovine Neonatal Pancytopenia (BNP) is a disease of calves characterised by bone marrow trilineage
hypoplasia, mediated by ingestion of alloantibodies in colostrum. Suspected subclinical forms of BNP have been
reported, suggesting that observed clinical cases may not represent the full extent of the disease. However to date
there are no objective data available on the incidence of subclinical disease or its temporal distribution. This study
aimed to 1) ascertain whether subclinical BNP occurs and, if so, to determine the incidence on an affected farm
and 2) determine whether there is evidence of temporal clustering of BNP cases on this farm. To achieve these
aims, haematological screening of calves born on the farm during one calving season was carried out, utilising
blood samples collected at defined ages. These data were then analysed in comparison to data from both known
BNP-free control animals and histopathologically confirmed BNP cases. An ordinal logistic regression model was
used to create a composite haematology score to predict the probabilities of calves being normal, based on their
haematology measurements at 10–14 days old.
Results: This study revealed that 15% (21 of 139) of the clinically normal calves on this farm had profoundly
abnormal haematology (<5% chance of being normal) and could be defined as affected by subclinical BNP.
Together with clinical BNP cases, this gave the study farm a BNP incidence of 18%. Calves with BNP were found to
be distributed throughout the calving period, with no clustering, and no significant differences in the date of birth
of cases or subclinical cases were found compared to the rest of the calves. This study did not find any evidence of
increased mortality or increased time from birth to sale in subclinical BNP calves but, as the study only involved a
single farm and adverse effects may be determined by other inter-current diseases it remains possible that subclinical
BNP has a detrimental impact on the health and productivity of calves under certain circumstances.
Conclusions: Subclinical BNP was found to occur at a high incidence in a herd of cattle with fatal cases of BNP.
Keywords: Bovine Neonatal Pancytopenia (BNP), Haematology, Subclinical, Alloantibody
Background
Bovine Neonatal Pancytopenia (BNP) is a recently emerged
disease of calves that has been described across Europe
since 2007 [1] and in New Zealand since 2011 [2]. It
presents as a bleeding disorder of calves less than one
month old resulting in a high level of mortality in clinic-
ally affected calves [1,3] due to bone marrow trilineage
hypoplasia [4] accompanied by depletion of peripheral
thrombocytes and leukocytes. The disease is mediated
by ingestion of alloantibodies in colostrum from particular
cows [5,6] and the subsequent binding of these alloanti-
bodies to calf hematopoietic cells [7,8], leading to functional
compromise of bone marrow hematopoietic progenitors
[9]. BNP is strongly associated with the use of a particular
Bovine Viral Diarrhoea Virus (BVDV) vaccine (Pregsure
BVD; Pfizer Animal Health) in the dams of affected calves
[10,11] suggesting this vaccine induces alloantibody
production in BNP dams. Furthermore, antibodies in
serum from BNP-dams have been shown to react with
the bovine kidney cell line used to generate the viral
antigen incorporated in Pregsure [9] and also to recognise
bovine MHC class I (MHC I) proteins [12,13] indicating
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that the stimulus for alloantibody production may be cell
culture components within the vaccine.
Between March 2009 and February 2011 more than
4,500 confirmed cases of BNP were reported across Europe
[14]. It is likely that this figure is an underestimate as
considerable under-reporting of cases is known to occur
[15] but nevertheless the incidence of clinical BNP on
most affected farms is low, often with only one case per
farm, rarely up to 10% [3,11]. These clinical cases may
not represent the full extent of the disease, as suspected
subclinical forms of BNP have been observed [3,16,17],
where apparently healthy calves on BNP affected farms
have been shown to have hematological profiles that ap-
pear abnormal. However, these findings were based on
small numbers of animals of various/unspecified ages,
in some cases with incomplete hematological data, and
there has been no attempt to assess the extent of sub-
clinical abnormalities in BNP-affected herds. Moreover,
the precise definition of what constitutes an abnormal
hematological profile in the affected age group of calves
is currently problematic because of limited available in-
formation on the normal haemogram of calves in the
postnatal period, which is known to differ significantly
from adult cattle [18] and to change significantly with
the age of the calf [19,20].
Temporal clustering of clinical BNP cases has been
noticed on affected farms both within a single calving
period [16,17] and seasonally [1,3,21]. Although this
might be expected on dairy farms where colostrum is
frequently pooled, such observations also come from
beef herds where cross-suckling is unlikely. However
thorough assessment of the temporal pattern of BNP
requires inclusion of all calves affected by BNP, both
clinical and subclinical, and therefore a clearer definition
of all forms of the disease is necessary for appropriate
analysis.
The aims of this study were 1) to ascertain whether sub-
clinical BNP occurs and, if so, to determine the incidence
on one affected farm and 2) to determine whether tem-
poral clustering of BNP occurs on this farm. To achieve
this, widespread haematological screening of calves was
carried out on one BNP affected farm, with collection of
samples at defined ages. These data were then analysed
in comparison to both known BNP-free control animals
and histopathologicically confirmed BNP cases. Further-
more, production data from the farm were analysed in
order to assess the long-term impact of subclinical BNP
on calves.
Materials and methods
Farms
The farm used for the investigation of subclinical BNP
incidence (farm A) was a 200-cow, crossbred beef suck-
ler herd, which had a 5% incidence of BNP in 2009 [16].
Sample collection on this farm took place during calving
in spring 2010. Cows had been vaccinated with Pregsure
BVD since 2007 and a booster vaccination was given in
2009, during the pregnancy from which calves were sub-
sequently sampled. Throughout the study cows and
calves were managed according to normal practice on
that farm, with farm staff diligently ensuring prompt col-
ostrum ingestion by calves. All calves suckled their own
dams and no cross-suckling was observed. Calves were
sired by natural service with ten bulls of three different
breeds, providing a broad genetic background. Overall,
during the 9 week peak period of spring calving samples
were obtained from 143 calves from a total of 172 born
(83%), and of these 4 showed clinical signs of BNP (see
below).
Two BVDV-free and BVDV-unvaccinated dairy farms
(farms B and C), with no known cases of BNP, supplied
both calves and colostrum that served as controls.
Calves
A summary of the groups of calves is provided in Table 1.
Calves with no clinical signs of BNP (Group 1, n = 139)
These comprised calves that showed no clinical signs of
BNP, born during 2010 to dams on farm A with no history
of producing a BNP affected calf. All calves were observed
Table 1 Summary of the groups of calves used in the study
Group Number
of Calves
BNP status Farm of
origin
BVDV vaccination
status of dam
BVDV vaccination status of dam from
which colostrum was ingested
Bone marrow
histopathology
1 139 Unknown – no clinical
signs of BNP
A Vaccinated Vaccinated (own dam) No
2a 14 BNP (Field cases) A and similar
local farms
Vaccinated Vaccinated (own dam) Yes
2b 5 BNP (Experimentally
induced disease [22])
B and C Unvaccinated Vaccinated (not own dam) Yes
3a 8 Unaffected normal A Vaccinated Unvaccinated (not own dam) No
3b 7 Unaffected normal A Unvaccinated Unvaccinated (own dam) No
3c 5 Unaffected normal
(Experimental controls [22])
B and C Unvaccinated Unvaccinated (not own dam) Yes
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daily by a veterinary surgeon for the first 10–14 days of
life, and daily thereafter by the farmer, and any calves that
appeared abnormal were given a full clinical examination
for signs indicative of BNP.
BNP cases (Group 2, total n = 19)
These comprised calves with clinical signs of BNP, born
to dams on farm A in 2010 (n = 4) and 2009 (n = 4), and
born to dams on five similar local farms in 2009 (n = 6).
Of these 14 field cases (group 2a), 3 survived, while the
remaining 11 fatal cases were confirmed by bone mar-
row histopathology. All these field cases showed typical
clinical signs of BNP on examination by a veterinary
surgeon. In addition, data was included from cases of
BNP induced experimentally by feeding colostrum from
BNP-dams on farm A to calves from farms B and C
(group 2b, n = 5) [22]. These cases were euthanased at
10 days post-colostrum ingestion and in all cases bone
marrow histopathology showed lesions consistent with
BNP. Together these cases represent a broad range of se-
verity of BNP that is typical of what is seen in the field.
Normal calves (Group 3, n = 20)
Calves that had been fed only colostrum from Pregsure
unvaccinated cows were considered normal, as they were
not exposed to any known potential source of BNP. These
comprised two groups of calves from farm A; those that
were born to BNP-dams in 2010 that were fed substitute
colostrum from BVDV-unvaccinated cows (group 3a, n =
8) [23] and calves born in 2011 to dams that had not been
vaccinated with Pregsure (group 3b, n = 7). In addition,
data were included from experimental control calves from
farms B and C (group 3c, n = 5) fed colostrum from cows
on farms B and C [22]. None of these calves showed any
clinical signs of BNP, and in the experimental calves bone
marrow histopathology at necropsy at 10 days old was
within normal limits.
Blood sampling and haematology
For all calves a single blood sample was collected by
jugular venepuncture at 10–14 days old and transferred
immediately into a K-EDTA collection tube. Haemato-
logical parameters (erythrocyte, thrombocyte and total
leukocyte counts) were measured with an automated
haematology analyser (Beckman Coulter Ac. T5 impedance
counter, Beckman Coulter, UK) and differential leukocyte
counts were performed manually on a freshly prepared
blood smear stained with a Romanowsky stain (Reastain
Quick Diff, Reagena, Finland). Blood was processed within
24 hours of collection, a timeframe which, in contrast to
adult cattle, has been demonstrated to provide a reprodu-
cible thrombocyte count in young calves [20], and no
signs of thrombocyte clumping were observed on manual
verification of a blood smear.
The 10–14 day time point was selected for investigation
of subclinical BNP because, in BNP cases, it represents a
nadir in haematological values and thus the period during
which haematological abnormalities related to BNP might
most easily be detected [5]. Moreover, for both normal
calves and BNP, large changes in haematological parame-
ters occur in the first week of life [18,22] and thus later
sampling is less subject to such variation and allows a lar-
ger window for sample collection.
Samples were also collected at < 24 hours old from 136
calves in group 1, four calves in group 2a and all calves
in groups 2b, 3a and 3c, and analysed using the same
methods. Calves in group 2b and 3c were sampled on
seven set occasions during the first 24 hours, all post-
colostrum ingestion, and therefore a mean value was cal-
culated for each parameter and used for further analysis.
For all other groups only a single sample was collected
during the first 24 hours irrespective of the time of col-
ostrum ingestion.
Statistical analysis of haematology results
Samples collected at 10–14 days were analysed first, and
measurements from calves in group 2 (n = 19) were used
to define the haematological profile of a BNP case and
group 3 (n = 20) were used to define the haematological
profile of a normal calf. Haematological parameters for
these groups were compared using t-tests, when the logs
of measurements were normally distributed, and Wilcoxon
rank sum tests for other measurements (basophils and
eosinophils), in order to determine which parameters
differed significantly between the two groups. In addition,
these tests were carried out separately for samples collected
at < 24 hours after birth.
An ordinal logistic regression model was used to create
a composite hematology score to predict probabilities of
calves being normal, based on their haematology measure-
ments at 10–14 days old. The disease status of calves was
ordered as; BNP cases (group 2), calves with no clinical
signs of BNP (group 1) and normal calves (group 3).
Haematology measurements were entered into the
model one-by-one (ie using forward selection) until no
further measurements had a p-value of less than 0.20.
Natural logarithms of measurements were used when
these provided a more symmetrical distribution (all mea-
surements except basophils and eosinophils); otherwise
untransformed values (basophils and eosinophils) were
used. Inclusion of the group 1 calves in this analysis
allowed the model to utilise the partial information on
disease status (ie. not clinical BNP but not known whether
normal) available from this large group of calves. The co-
efficients from the logistic equation were used to form an
additive score from the combined haematology measure-
ments, and the distribution of scores obtained for the nor-
mal calves (group 3) was used to identify calves with low
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probability of being normal based on hematology mea-
surements at 10–14 days. This was achieved by assuming
a normal distribution for the scores of normal calves
(group 3) and obtaining the 5% lower tail. Calves in group
1 with scores below this point were defined as affected by
subclinical BNP.
Calves defined by the model as affected by subclinical
BNP were then separated from the other calves in group
1. Individual haematology parameters at < 24 hours for
the subclinical calves were compared to those in the re-
mainder of group 1 using t-tests when the logs of mea-
surements were normally distributed, and Wilcoxon rank
sum tests for other measurements (basophils and eosino-
phils), in order to investigate whether subclinical calves
showed significant alterations in haematology at < 24 hour
old. Additionally mortality was compared between the
subclinical calves and the remainder of group 1 using a
Fisher’s exact test. Statistical analyses were performed
using SAS/STAT® software and GenStat, VSN International,
(version 13).
Determining the temporal pattern of BNP
A Monte Carlo simulation approach was used to deter-
mine whether the birth dates of the four BNP cases ob-
served on farm A in 2010, or the four BNP cases plus
the subclinical BNP calves, were significantly clustered
in time. First all possible clusters across time and with
varying lengths of cluster period (4–14 days) were con-
sidered and the ‘best’ cluster with the highest likelihood
was determined. To determine if the likelihood of this
‘best’ cluster was higher than expected by chance, the
distribution of maximum likelihood values expected under
no clustering was obtained using Monte Carlo simulation.
First 1000 examples of daily case and control numbers oc-
curring were simulated under the expectation of an even
ratio cases/controls across time; the maximum likelihood
for the ‘best’ clusters was then obtained for each simulated
example (just as for the observed data); then these 1000
maximum likelihood values were used to provide the re-
quired ‘null’ distribution. The significance of the max-
imum likelihood value for the observed data was obtained
by comparing it to this distribution.
Additionally, t-tests were used to compare the distribu-
tion of birth dates for BNP calves with both subclinical
calves and the remainder of group 1, and to compare the
distribution of birth dates of subclinical calves with the re-
mainder of group 1.
Calf production data
All calves from farm A were sold at final slaughter weight.
Records of days from birth to sale were available for 127
of the 139 calves of unknown BNP status (group 1), and
these were used as an indicator of production perform-
ance from birth to slaughter. To assess the impact of
abnormal haematology at 10–14 days on subsequent
production performance, days from birth to sale were
analysed using a Cox regression model which fitted
composite haematology score and date of birth (hence
adjusting for any influence of time of birth on age at
sale). Calves that died from non-BNP causes prior to
sale were included as censored observations, and calves
retained for breeding and not sold were excluded from
the analysis.
Ethical considerations
Blood sampling of calves from the BNP affected farm
(farm A) was undertaken for veterinary disease investi-
gation purposes after consultation with the UK Home
Office and review by the Royal (Dick) School of Veterin-
ary Studies Ethical Review Committee. Calves in groups
2b and 3c (experimentally induced BNP cases and ex-
perimental controls) were sampled as part of a study
conducted at the Moredun Research Institute, UK. These
calves were managed in accordance with the UK Animals
(Scientific Procedures) Act 1986 and the experiment
was approved by the Moredun Ethical Review Committee
(experiment number 51/10).
Results
Analysis of haematology parameters at 10–14 days old
A summary of the haematology results obtained at 10–
14 days old for the three groups of calves is provided in
Table 2. In samples taken at 10–14 days old, haematol-
ogy parameters in case calves (group 2) were signifi-
cantly lower than those in normal calves (group 3) for
thrombocytes (p < 0.001), monocytes (p < 0.002), eryth-
rocytes (p < 0.001), lymphocytes (p < 0.001), neutrophils
(p < 0.001), band neutrophils (p = 0.03), and basophils
(p = 0.05), in accordance with other studies [22]. How-
ever, the significance of band neutrophils and basophils
should be considered borderline given the multiple tests
carried out. There was no significant difference between
the groups for eosinophils (p = 0.61).
The results of the ordinal logistic regression analysis
are shown in Table 3. The following composite haema-
tology score was obtained using the coefficients of this
model and used to predict the likelihood of individual
calves being affected by BNP based on measurements
taken at 10–14 days after birth:
Score ¼ 1:46 x log monocytesþ 1ð Þ þ 2:52
x log lymphocytesþ 1ð Þ þ 1:29
x log thrombocytes þ 1ð Þ þ 3:59
x log band neutrophilsþ 1ð Þ þ 4:64 x basophils
Means and standard deviations for the composite
haematology scores for each group of calves are shown
in Table 2. Thrombocytes and lymphocytes made the
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greatest contributions to the score when judged by the
coefficient sizes of a model equivalently defined in
terms of standardised haematology values (ie divided
by their standard deviations).
Overall the composite haematology scores for calves in
the BNP-affected herd (group 1) were significantly lower
(p < 0.001) than that of the normal calves (group 3) (t-test).
The distributions of composite haematology scores for
groups 1, 2 and 3 are shown in Figure 1.
Determining the incidence of subclinical disease
Based on the distribution of scores of normal calves
(group 3), calves with a composite haematology score of
less than 11.68 were predicted to have a less than 5%
chance of being normal. Fifteen percent (21 of 139) of
the calves in group 1 that showed no overt signs of BNP
had composite haematology scores below this value and
therefore could be defined as being subclinically affected
by BNP. Scores of the BNP cases (group 2) and normal
calves (group 3) were completely separated and no nor-
mal calves had scores below the threshold used to define
the subclinical calves, and no BNP cases had scores
above it (Figure 1).
Analysis of haematology parameters at <24 hours old
A summary of the haematology results obtained at <24 hours
old for the three groups of calves, is provided in Table 2.
In samples taken at < 24 hours old, haematology parame-
ters in case calves (group 2) were significantly lower than
those in normal calves (group 3) for monocytes (p = 0.005),
thrombocytes (p = 0.05) and neutrophils (p = 0.02). There
was no significant difference between the groups for lym-
phocytes (p = 0.1), erythrocytes (p = 0.23), band neutrophils
(p = 0.57), eosinophils (p = 0.49) and basophils (p = 0.20),
although statistical power of these tests was low with only
9 BNP cases and 13 normal calves available. Furthermore
the significance of thrombocytes and neutrophils should
Table 2 Summary haematology results and composite haematology scores obtained for each group of calves
Haematology results
at 10–14 days
Calves with no clinical
signs of BNP (Group 1)
Clinical BNP cases (Group 2) Normal calves
(Group 3)
Calves from group 1 identified by the
models as affected by subclinical BNP
Erythrocytes (×1012/L) 7.69 (6.35-9.03) 5.87 (3.87-7.87) 8.35 (6.96-9.74) 7.77 (6.31-9.23)
Thrombocytes (×109/L) 812 (476–1148) 52 (0–140) 844 (624–1064) 401 (192–610)
Total leukocytes (×109/L) 11.64 (7.86-15.42) 2.53 (0.83-4.23) 13.60 (8.35-18.85) 7.64 (4.50-10.78)
Segmented neutrophils (x109/L) 6.96 (3.73-10.19) 1.28 (0–3.09) 7.07 (2.51-11.63) 5.19 (2–8.38)
Band neutrophils (×109/L) 0.07 (0–0.28) 0.02 (0–0.07) 0.30 (0–0.83) 0.02 (0–0.07)
Lymphocytes (×109/L) 4.19 (2.45-5.92) 1.17 (0–2.05) 4.84 (2.92-6.76) 2.25 (1.46-3.04)
Monocytes (×109/L) 0.35 (0–0.76) 0.02 (0–0.06) 0.86 (0–1.89) 0.11 (0–0.27)
Eosinophils (×109/L) 0.04 (0–0.15) 0.02 (0–0.09) 0.04 (0–0.12) 0.08 (0–0.23)
Basophils (×109/L) 0.02 (0–0.07) 0.00 (0–0) 0.09 (0–0.33) 0.00 (0–0.03)
Composite Haematology Score 13.17 (1.52) 4.55 (2.71) 14.87 (1.94)
Haematology results
at <24 hours
Calves with no clinical
signs of BNP (Group 1)
Clinical BNP cases (Group 2) Normal calves
(Group 3)
Calves from group 1 identified by the
models as affected by subclinical BNP
Erythrocytes (×1012/L) 8.75 (7.41-10.10) 8.37 (6.99-9.76) 8.92 (7.06-10.78) 9.13 (7.86-10.41)
Thrombocytes (×109/L) 375 (272–478) 335 (272–398) 504 (239–769) 292 (169–416)
Total leukocytes (×109/L) 12.16 (6.32-17.99) 9.86 (5.46-14.27) 16.50 (8.34-24.66) 8.82 (4.36-13.28)
Segmented neutrophils (×109/L) 9.12 (4.18-14.06) 7.27 (4.27-10.26) 12.58 (5.99-19.16) 6.83 (2.75-10.92)
Band neutrophils (×109/L) 0.63 (0–1.87) 0.93 (0.26-1.60) 0.87 (0.13-1.62) 0.44 (0–0.91)
Lymphocytes (×109/L) 2.12 (0.9-3.35) 1.54 (0–3.07) 2.72 (1.16-4.27) 1.39 (0–2.88)
Monocytes (×109/L) 0.20 (0–0.43) 0.05 (0.01-0.10) 0.25 (0.04-0.45) 0.08 (0–0.21)
Eosinophils (×109/L) 0.06 (0–0.21) 0.05 (0–0.12) 0.03 (0–0.11) 0.04 (0–0.14)
Basophils (×109/L) 0.02 (0–0.09) 0.00 (0–0) 0.04 (0–0.14) 0.01 (0–0.05)
Mean values are shown, with one standard deviation above and below the mean in parentheses.
Table 3 Results of the ordinal logisitic regression analysis
Estimate (SE)
(on logit scale)
p-value
Intercept 1 −16.03 (2.82) <0.0001
Intercept 2 −8.03 (2.12) 0.0002
Log(Monocytes +1) (x109/L) 1.46 (0.92) 0.11
Log(Lymphocytes +1) (x109/L) 2.52 (0.75) 0.0008
Log(Band neutrophils + 1) (x109/L) 3.59 (1.65) 0.03
Log(Thrombocytes + 1) (x109/L) 1.29 (0.39) 0.001
Basophils (x109/L) 4.64 (2.58) 0.07
Bell et al. BMC Veterinary Research 2014, 10:245 Page 5 of 9
http://www.biomedcentral.com/1746-6148/10/245
be considered borderline given the multiple tests car-
ried out.
At <24 hours old, calves subsequently identified by the
haematology score at 10–14 days as affected by subclin-
ical BNP had significantly lower haematological parame-
ters than the remainder of calves in group 1 for monocytes
(p < 0.001), thrombocytes (p < 0.001), lymphocytes (p =
0.002) and neutrophils (p = 0.02), but not for erythrocytes
(p = 0.16), band neutrophils (p = 0.17), eosinophils (p =
0.55) and basophils (p = 0.75) (see Table 2). Again the sig-
nificance of neutrophils should be considered borderline
given the multiple tests carried out. These results suggest
that the calves identified by the haematology score as af-
fected by subclinical BNP have significant alterations in
haematology in the first 24 hours of life and the observed
pattern of alterations in individual haematology parame-
ters is consistent with that observed in BNP cases used in
this study (group 2). This finding is particularly notable
given that samples were collected at a range of time-points
following colostrum ingestion, which would be expected
to result in variation on the severity of haematological
alternations in individual calves [16].
Assessing the long-term impact of subclinical BNP
Age at sale was associated with haematology score (p = 0.04)
and date of birth (p = 0.006). Calves with lower scores
and later dates of birth were significantly younger at
sale. The mean age at slaughter in subclinical calves was
461 days, compared to the remainder of group 1 with a
mean of 479 days. There was not a statistically significance
difference in mortality between the subclinical calves and
the remainder of group 1 (p = 0.6). While there was lim-
ited power to assess this difference, the lower mortality
rate of 0% in the subclinical calves compared to 4.3% in
the remainder of group 1 indicated that higher mortality
in subclinical calves was unlikely.
Determining the temporal pattern of BNP
The distribution of the normal calves, subclinical calves
and BNP calves in this herd by week of birth is shown in
Figure 2. While the mean days from the start of the calv-
ing period until birth was shorter in BNP cases (14 days)
than subclinical cases (26 days) or calves in the remainder
of group 1 (29 days), the differences were not significantly
different (BNP cases compared to group 1, p = 0.07; BNP
cases compared to subclinical cases, p = 0.06; subclinical
cases compared to remainder of group 1, p = 0.40). There
was also no significant clustering in birth dates of BNP
cases, or BNP cases plus subclinical cases, in this herd
during 2010.
Discussion
This study demonstrates that approximately 15% of
calves on a BNP affected farm had an abnormal haema-
tology profile at 10–14 days of age, but without showing
any overt clinical signs of BNP. The haematology param-
eters of these calves, although less severely affected than
in BNP cases, displayed a profile that is similar to that of
clinical cases. These findings, coupled with the absence
of such animals in the control populations, indicate that
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Figure 1 Frequency of calves with different composite haematology scores (rounded to integer values). Calves with no clinical signs of
BNP (group 1) – grey columns, BNP cases (group 2) - black columns, normal calves (group 3) - white columns. Calves with a composite haematology
score of <11.68 are predicted to have a less than 5% chance of being normal.
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these animals are likely to represent sub-clinical cases of
BNP. Furthermore, in a separate study (manuscript in
preparation) we have demonstrated that cows from this
BNP-affected herd that produced calves without clinical
signs of BNP have significantly higher titres of serum al-
loantibody than BVDV-unvaccinated cows, providing
supporting immunological evidence for these epidemio-
logical findings.
Together with the four clinical cases of BNP diagnosed
on the study farm in 2010, this gives an overall incidence
of BNP on this farm of 18%, with >5 subclinical cases of
BNP for every case with overt clinical signs. As the study
herd comprised cross-bred cows originating from across
the UK, and did not use special colostrum management
or colostrum pooling during the study period, these re-
sults suggest that the haematological manifestations of
BNP are much more widespread than indicated by the
incidence of overt clinical disease. However, as this study
was conducted on a single BNP-affected herd, caution
must be exercised in generalising these results to the
wider cattle population with differing management sys-
tems and genetic backgrounds and therefore further
studies on other herds using the model described would
be informative.
These findings can also be used to make inferences
about the proportion of cows producing BNP alloanti-
body. When calves are fed colostrum from individual
unrelated BNP-dams a proportion (roughly 1 in 3) do not
succumb to disease [6] presumably because they lack anti-
gens that are sufficiently complementary to the specific al-
loantibodies generated by that cow. When calves suckle
their own dams the proportion of calves unaffected by
BNP is likely to be even higher, as half their genetic mater-
ial will originate from the dam, reducing the likelihood of
susceptible antigens being present. The same rationale is
likely to apply to subclinical BNP, and thus the percentage
of cows producing BNP alloantibodies in this affected
herd is likely to be higher than 18%. This is supported by
studies investigating the implicated anti-bovine MHC I
antibodies, which have suggested that 50-100% of cows
vaccinated with Pregsure following the recommended
protocol may produce these antibodies [12,24].
Results from this study also demonstrate that BNP is
not an all-or-nothing response but rather that a con-
tinuum of disease exists. Variation in BNP severity, from
clinical to subclinical, could be influenced by differences
in the quantity and alloantibody titre of ingested colostral
antibody and the time from birth to suckling, all of which
will influence the amount of alloantibody passively trans-
ferred to the calf. In addition, a range of disease severity is
consistent with evidence that alloantibodies produced by
BNP dams are specific for highly polymorphic antigens
[8,12,13] which would be likely to display a complex pat-
tern of antigenic specificities leading to variable affinity to
calf cells of differing genotypes.
This study failed to find significant temporal clustering
of clinical or subclinical BNP or significant differences in
the date of birth of cases or subclinical cases compared
to the rest of the calves. During this study colostrum pool-
ing was not practised and calves were housed and man-
aged in a similar manner for the duration of the sampling
period. Previous reports of a temporal pattern in the oc-
currence of BNP cases [3,16,25] might therefore relate to
pooling of colostrum or variation in management factors
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Figure 2 Distribution of all calves sampled on farm A (n = 143) by week of calving. Calves are divided into; BNP cases (n = 4, black
columns), calves in group 1 identified as subclinical BNP cases by the model (n =21, grey columns) and the remaining calves from group 1
(n = 118, white columns).
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during the calving period which increase the likelihood
of BNP manifesting clinically. For example, concurrent
disease or mild trauma due to handling or crowding could
increase the likelihood of subclinical cases manifesting
clinically and might also explain the reduced risk of BNP
in calves kept outdoors [10]. As all dams in this study
were vaccinated with Pregsure at a single time point this
result also supports previous findings of no association
between the incidence of BNP and the time since last
Pregsure vaccination [10].
In this study, subclinical BNP did not increase calf
mortality or have a detrimental effect on long-term pro-
duction in terms of days to slaughter. However other
studies looking at larger numbers of farms with varied
management conditions have shown an increase in calf
morbidity attributed to causes other than BNP on af-
fected farms, since the appearance of the disease [15]. A
positive association has also been found between BNP
affected farms and the incidence of calf respiratory dis-
ease and treatments for neonatal calf diseases [11,15].
Lack of clinical signs of bleeding in subclinical cases of
BNP is consistent with redundancy of haemostatic mecha-
nisms which mean that only profound thrombocytopenia
(often <30×109/L) will lead to bleeding diathesis [26].
However profoundly abnormal haemograms due to sub-
clinical BNP, which include depressed lymphocyte and
monocyte counts, may result in immunosuppression,
providing a credible basis for the suggestion that sub-
clinical BNP could have an impact on calf health and
productivity in situations where animals are exposed to
pathogen challenge.
Conclusions
This study has demonstrated that on one BNP affected
farm 15% of clinically normal calves had profoundly ab-
normal haematology and could be defined as affected by
subclinical BNP. The haematology parameters of these
calves, although less severely affected than in BNP cases,
displayed a profile that is similar to that of clinical cases.
Calves with BNP were found to be distributed through-
out the calving period, with no clustering, and no sig-
nificant differences in the date of birth of cases or
subclinical cases were found compared the rest of the
calves. This study did not find any evidence of increased
mortality or increased time from birth to sale in sub-
clinical BNP calves but, given that this study only in-
volved a single farm, a detrimental impact of subclinical
BNP on the health and productivity of calves cannot be
ruled out.
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